Both in Biotechnology
Neurocrine Biosciences vs Repligen
Over the past year NBIX returned +2.9% and RGEN returned +16.0%; their daily moves had a correlation of 0.14.
NBIX +2.9% RGEN +16.0%Growth of $1, one year, split-adjusted
| Metric | NBIX | RGEN |
|---|---|---|
| Price | $146.09 | $174.17 |
| Market cap | $14.85B | $11.06B |
| Today | −0.01% | −1.57% |
| 1 month | +2.0% | −4.1% |
| 6 months | +9.0% | +47.3% |
| Year to date | +3.0% | +6.3% |
| 1 year | +5.8% | +20.5% |
| Revenue growth (YoY) | +39.5% | +10.9% |
| Gross margin | 97.6% | 53.0% |
| Net margin | 15.1% | −18.4% |
| P/E (TTM) | 21.0× | — |
| Price / sales | 4.4× | 13.7× |
| Net cash | $389.8M | $307.4M |
| Dividend yield | — | — |
| Volatility (60d) | 25.9% | 46.8% |
| Short % of float | 6.6% | 12.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).